Sunday, March 29, 2026

Kim Jong Un Era Declared ‘Golden Age of Naval Power’ as Third Destroyer Planned

North Korea announced plans to build a third 5,000-ton destroyer by October 10 of next year.

Samsung SDI Set for Growth: Will U.S. Restrictions on Chinese ESS Boost Stock by 52%?

Daol Investment & Securities raises Samsung SDI's target price, citing benefits from U.S. restrictions on Chinese energy storage systems.

Korean Pharma in Trump’s Crosshairs: A 25% Tariff Threat—and Why U.S. Drug Prices Could Be the Real Risk

The U.S. plans a 25% tariff on Korean pharmaceuticals, raising concerns for both industries amid potential impacts on U.S. consumers.

Tag: Leclaza

NCCN Endorses Leclaza and Rybrevant Combo as Top Lung Cancer Treatment: What You Need to Know

NCCN guidelines now classify Leclaza + Rybrevant as a preferred first-line treatment for lung cancer, enhancing patient access and management.

Top News

- Our Sponsors Ad -

Follow us